BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 31446304)

  • 21. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
    Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D
    Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of Surgery Alone and Surveillance Strategy in Young Women With Stage I Malignant Ovarian Germ Cell Tumors.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2016 Jun; 26(5):859-64. PubMed ID: 27101582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tailored therapy and long-term surveillance of malignant germ cell tumors in the female genital system: 10-year experience.
    Zhao Q; Yang J; Cao D; Han J; Xu K; Liu Y; Shen K
    J Gynecol Oncol; 2016 May; 27(3):e26. PubMed ID: 27029747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective study of reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors and sex cord-stromal tumors.
    Zhang N; Chen R; Hua K; Zhang Y
    J Ovarian Res; 2017 Jul; 10(1):52. PubMed ID: 28750644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of malignant ovarian germ cell tumors with relapse or failed in primary therapy].
    Yang JX; Wang HB; Shen K; Huang HF; Pan LY; Wu M
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):273-6. PubMed ID: 19570465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is Omentectomy Mandatory Among Early Stage (I, II) Malignant Ovarian Germ Cell Tumor Patients? A Retrospective Study of 223 Cases.
    Xu W; Li Y
    Int J Gynecol Cancer; 2017 Sep; 27(7):1373-1378. PubMed ID: 28520571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of bilateral malignant ovarian germ cell tumors: a MITO-9 retrospective study.
    Sigismondi C; Scollo P; Ferrandina G; Candiani M; Angioli R; Viganò R; Scarfone G; Mangili G
    Int J Gynecol Cancer; 2015 Feb; 25(2):203-7. PubMed ID: 25569816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009).
    Solheim O; Kærn J; Tropé CG; Rokkones E; Dahl AA; Nesland JM; Fosså SD
    Gynecol Oncol; 2013 Nov; 131(2):330-5. PubMed ID: 24001518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors.
    Ertas IE; Taskin S; Goklu R; Bilgin M; Goc G; Yildirim Y; Ortac F
    J Obstet Gynaecol Res; 2014 Mar; 40(3):797-805. PubMed ID: 24320102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reproductive outcomes of 105 malignant ovarian germ cell tumor survivors: a multicenter study.
    Tamauchi S; Kajiyama H; Yoshihara M; Ikeda Y; Yoshikawa N; Nishino K; Utsumi F; Niimi K; Suzuki S; Kikkawa F
    Am J Obstet Gynecol; 2018 Oct; 219(4):385.e1-385.e7. PubMed ID: 30086295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fertility-sparing surgery in advanced stage malignant ovarian germ cell tumor: a case report.
    Ghalleb M; Bouzaiene H; Slim S; Hadiji A; Hechiche M; Ben Hassouna J; Rahal K
    J Med Case Rep; 2017 Dec; 11(1):350. PubMed ID: 29248013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 8-year analysis of the prevalence of lymph nodes metastasis, oncologic and pregnancy outcomes in apparent early-stage malignant ovarian germ cell tumors.
    Chatchotikawong U; Ruengkhachorn I; Leelaphatanadit C; Phithakwatchara N
    Asian Pac J Cancer Prev; 2015; 16(4):1609-13. PubMed ID: 25743840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinicopathological study of malignant ovarian germ cell tumor].
    Kataoka A; Yakushiji M; Nishida T; Oda T; Kojiro M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):695-701. PubMed ID: 2549132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours.
    Gadducci A; Lanfredini N; Tana R
    Gynecol Endocrinol; 2014 Jul; 30(7):467-71. PubMed ID: 24702194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian germ cell tumors.
    Cusidó MT; Jordá B; Gonzalez J; García A; Xercavins J
    Eur J Gynaecol Oncol; 1998; 19(2):130-4. PubMed ID: 9611051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study.
    Mangili G; Sigismondi C; Gadducci A; Cormio G; Scollo P; Tateo S; Ferrandina G; Greggi S; Candiani M; Lorusso D
    Int J Gynecol Cancer; 2011 Nov; 21(8):1414-21. PubMed ID: 21795985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fertility management for malignant ovarian germ cell tumors patients.
    Di Tucci C; Casorelli A; Morrocchi E; Palaia I; Muzii L; Panici PB
    Crit Rev Oncol Hematol; 2017 Dec; 120():34-42. PubMed ID: 29198336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian germ cell tumors in children: a 20-year retrospective study in a single institution.
    Yang C; Wang S; Li CC; Zhang J; Kong XR; Ouyang J
    Eur J Gynaecol Oncol; 2011; 32(3):289-92. PubMed ID: 21797119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multicenter and retrospective study.
    Chu R; Liu P; Chen J; Cheng X; Li K; Che Y; Wang J; Li L; Zhang X; Yao S; Song L; Zhao Y; Huang C; Xue Y; Pan X; Li J; Chen Z; Jiang J; Kong B; Song K
    J Gynecol Oncol; 2023 Mar; 34(2):e12. PubMed ID: 36890292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Childhood malignant ovarian germ cell tumors: a monoinstitutional experience.
    Terenziani M; Massimino M; Casanova M; Cefalo G; Ferrari A; Luksch R; Spreafico F; Polastri D; Fontanelli R; Piva L; Fossati-Bellani F
    Gynecol Oncol; 2001 Jun; 81(3):436-40. PubMed ID: 11371135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.